BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7652764)

  • 1. Alloantigens introduced into the anterior chamber of the eye induce systemic suppression of delayed hypersensitivity to third-party alloantigens through "linked recognition".
    Niederkorn JY; Mayhew E; He Y
    Transplantation; 1995 Aug; 60(4):348-54. PubMed ID: 7652764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune privilege in the anterior chamber of the eye: alloantigens and tumour-specific antigens presented into the anterior chamber simultaneously induce suppression and activation of delayed hypersensitivity to the respective antigens.
    Benson JL; Niederkorn JY
    Immunology; 1992 Oct; 77(2):189-95. PubMed ID: 1427974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the suppressor cell(s) responsible for anterior chamber-associated immune deviation (ACAID) induced in BALB/c mice by P815 cells.
    Streilein JW; Niederkorn JY
    J Immunol; 1985 Mar; 134(3):1381-7. PubMed ID: 3155766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune privilege in the anterior chamber of the eye is not extended to intraocular Listeria monocytogenes.
    Li XY; Niederkorn JY
    Ocul Immunol Inflamm; 1997 Dec; 5(4):245-57. PubMed ID: 9455741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma delta T cells are needed for ocular immune privilege and corneal graft survival.
    Skelsey ME; Mellon J; Niederkorn JY
    J Immunol; 2001 Apr; 166(7):4327-33. PubMed ID: 11254685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of delayed hypersensitivity to alloantigens coinjected with Langerhans cells into the anterior chamber of the eye. Abrogation of anterior chamber-associated immune deviation.
    Williamson JS; Streilein JW
    Transplantation; 1989 Mar; 47(3):519-24. PubMed ID: 2493700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anterior chamber inoculation of splenocytes without Fas/Fas-ligand interaction primes for a delayed-type hypersensitivity response rather than inducing anterior chamber-associated immune deviation.
    Kawashima H; Yamagami S; Tsuru T; Gregerson DS
    Eur J Immunol; 1997 Oct; 27(10):2490-4. PubMed ID: 9368601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressor T cell recognition of major and minor histocompatibility alloantigens: selected suppression of MHC-directed responses by minor alloantigen Ts.
    Perry LL; Williams IR; Dirusso S
    J Immunol; 1984 Jul; 133(1):16-23. PubMed ID: 6202781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The presence of donor-derived class II-positive cells abolishes immune privilege in the anterior chamber of the eye.
    Benson JL; Niederkorn JY
    Transplantation; 1991 Apr; 51(4):834-8. PubMed ID: 2014538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exogenous recombinant interleukin-2 abrogates anterior-chamber-associated immune deviation.
    Niederkorn JY
    Transplantation; 1987 Apr; 43(4):523-8. PubMed ID: 2953091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of splenic B cells in the immune privilege of the anterior chamber of the eye.
    Niederkorn JY; Mayhew E
    Eur J Immunol; 1995 Oct; 25(10):2783-7. PubMed ID: 7589072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that peritoneal exudate cells cultured with eye-derived fluids are the proximate antigen-presenting cells in immune deviation of the ocular type.
    Hara Y; Okamoto S; Rouse B; Streilein JW
    J Immunol; 1993 Nov; 151(10):5162-71. PubMed ID: 8228216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anterior chamber-associated immune deviation promotes corneal allograft survival.
    Niederkorn JY; Mellon J
    Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2700-7. PubMed ID: 8977485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Th1 and Th2 cells in anterior chamber-associated immune deviation.
    Li XY; D'Orazio LT; Niederkorn JY
    Immunology; 1996 Sep; 89(1):34-40. PubMed ID: 8911137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implication for the CD94/NKG2A-Qa-1 system in the generation and function of ocular-induced splenic CD8+ regulatory T cells.
    Chattopadhyay S; O'Rourke J; Cone RE
    Int Immunol; 2008 Apr; 20(4):509-16. PubMed ID: 18359787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1 abrogates anterior chamber-associated immune deviation.
    Benson JL; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1990 Oct; 31(10):2123-8. PubMed ID: 1698740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the induction of anterior chamber-associated immune deviation (ACAID). II. Eye-derived cells participate in generating blood-borne signals that induce ACAID.
    Wilbanks GA; Mammolenti M; Streilein JW
    J Immunol; 1991 May; 146(9):3018-24. PubMed ID: 2016537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of antigraft immunity by preimmunization. III. Characterization of suppressor T cells involved in suppression of the efferent phase of DTH against alloantigens.
    Bianchi AT; Hussaarts-Odijk LM; Wolters EA; Molendijk A; Benner R
    J Immunol; 1986 Jul; 137(2):433-42. PubMed ID: 2941481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alloantigen presentation to the anterior chamber of the eye subverts specific in vitro cell-mediated immune responses.
    Whittum JA; Niederkorn JY; Streilein JW
    Transplantation; 1982 Oct; 34(4):190-5. PubMed ID: 6183804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of cell-mediated immune responses elicited by orthotopic corneal allografts in mice.
    Sonoda Y; Sano Y; Ksander B; Streilein JW
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):427-34. PubMed ID: 7843911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.